Tongling Jieya Biotechnology Co., Ltd. achieved operating revenue of approximately RMB 192 million in the first quarter of 2026, representing a year-on-year increase of 55.45%. Net profit attributable to shareholders of the listed company was approximately RMB 10.2685 million, up 2.04% year-on-year.